DB09126ApprovedInvestigationalVet approvedProtein Based TherapiesGonadotropinsGonadotropins and Antigonadotropins
Chorionic Gonadotropin (Human) is a naturally-occurring hormone produced during human placenta used for the treatment of prepubertal cryptorchidism and hypogonadotropic hypogonadism in selected males, and induction of pregnancy in selected infertile women. Endogenously produced HCG interacts with the LHCG receptor of the ovary and promotes the maintenance of the corpus luteum during the beginning of pregnancy.
- Mechanism
- Curator reviewed
Pharmacologically active on Lutropin-choriogonadotropic hormone receptor
- Primary indication
- For the treatment of prepubertal cryptorchidism (not due to anatomical obstruction), for the treatment of selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males and for the induction of ovulation and...Curator reviewed · 5 structured indications
- First approval
- Canada, 2015 · United States, 1974
- Also known as
- Chorionic gonadotrophin · Chorionic gonadotropin · Gonadotropin, Chorionic · Gonadotropin,chorionic · h-HCG
- Brand names
Resolves to
Clinical / RWD
Targets
What you can answer from here — as of June 15, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Chorionic Gonadotropin (Human), and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account